No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
194 |
4. Check minimum number of eventsNone |
194 |
5. Include endpointsNone |
194 |
6. Filter based on genotype QC (FinnGen only) |
191 |
Control definitions (FinnGen only)
- Control exclude
- H7_VITREOUS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF6
Similar endpoints
↥List of similar endpoints to
Other endophthalmitis
based on the number of shared cases.
Similar with more cases:
- Disorders of globe
- Disorders of vitreous body and globe
- Diseases of the eye and adnexa
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1770 | 938 | 814 |
| Only index persons | 1405 | 776 | 629 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.03 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 66.80 | 71.11 | 61.85 |
| Only index persons | 65.42 | 70.24 | 59.47 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 191 | 108 | 83 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 63.93 | 64.60 | 63.06 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 194
- Matched controls
- 1940
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H44.1
ICD-10 Finland
Other endophthalmitis
+∞
212.7
163
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
34.8
124.1
91
48
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
50.0
94.1
57
16
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
20.6
61.1
51
33
WX140
NOMESCO Finland
Parabulbar anesthesy
16.7
58.2
55
45
CKA10
NOMESCO Finland
Biopsy of vitreous body
+∞
54.8
50
*
H44.0
ICD-10 Finland
Purulent endophthalmitis
+∞
52.5
48
*
S01ED51
ATC
timolol, combinations; ophthalmic
7.8
32.2
53
89
Z96.1
ICD-10 Finland
Presence of intraocular lens
5.9
31.9
82
214
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
7.1
30.9
57
108
XCW99
NOMESCO Finland
Other investigative procedure of eye
6.5
28.6
58
120
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
9.8
28.3
36
44
S01ED01
ATC
timolol; ophthalmic
11.3
26.6
30
31
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
8.9
25.0
34
45
H43.1
ICD-10 Finland
Vitreous haemorrhage
+∞
24.5
23
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
99.6
24.3
26
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.7
23.3
74
223
XCK10
NOMESCO Finland
Photography of fundus of eye
5.5
21.7
51
119
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
4.3
21.7
123
561
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
41.0
18.0
22
6
H33.0
ICD-10 Finland
Retinal detachment with retinal break
17.4
16.7
26
17
H26.4
ICD-10 Finland
After-cataract
4.4
15.8
47
131
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
3.4
15.5
113
569
36609
ICD-8 Finland
Other inflammation of uveal tract, Unspecified
+∞
14.8
14
*
TCK20
NOMESCO Finland
Needle biopsy of vitreous body
+∞
14.8
14
*
XCH00
NOMESCO Finland
Eye pressure measurement
6.4
14.6
26
46
CJB10
NOMESCO Finland
Laser discission of secondary cataract
4.3
13.7
41
114
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
43.4
13.4
16
*
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
+∞
12.6
12
*
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
40.4
12.4
15
*
H43.8
ICD-10 Finland
Other disorders of vitreous body
17.9
11.9
18
11
WX142
NOMESCO Finland
Sub-tenon anesthesy
69.3
11.8
13
*
S01EE01
ATC
latanoprost; ophthalmic
4.6
11.3
29
71
XCK00
NOMESCO Finland
Perimetry
4.7
11.2
28
67
H16.0
ICD-10 Finland
Corneal ulcer
5.8
10.9
21
40
S01EA05
ATC
brimonidine; ophthalmic
13.1
10.6
18
15
TCH12
NOMESCO Finland
Sample aspiration from anterior chambre
+∞
10.5
10
*
CKC12
NOMESCO Finland
Photocoagulation of retina
10.0
10.3
20
22
WX002
NOMESCO Finland
Sedation and analgesia
3.0
10.0
56
232
114
Kela drug reimbursment
Glaucoma
3.6
10.0
37
119
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
27.7
9.9
13
5
XCD20
NOMESCO Finland
Photoangiography of eye
10.9
9.8
18
18
H26.2
ICD-10 Finland
Complicated cataract
58.0
9.7
11
*
H02AB06
ATC
prednisolone; systemic
2.6
9.6
115
695
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
31.8
9.5
12
*
H3603, E103,
ICD-10 Finland
104.9
9.5
10
*
H25.1
ICD-10 Finland
Senile nuclear cataract
2.6
9.4
90
488
S01BA04
ATC
prednisolone; ophthalmic
9.8
9.3
18
20
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.5
9.2
110
661
S01BA07
ATC
fluorometholone; ophthalmic
16.6
9.2
14
9
CKD40
NOMESCO Finland
Endophotocoagulation of retina
13.4
9.0
15
12
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
11.5
9.0
16
15
S01EC01
ATC
acetazolamide; systemic
8.3
8.9
19
25
S01BC03
ATC
diclofenac; ophthalmic
12.4
8.7
15
13
ZXA00
NOMESCO Finland
Right side
2.5
8.6
74
378
ZXD05
NOMESCO Finland
Urgent procedure
2.5
8.6
75
387
36402
ICD-8 Finland
Iritis, Iridocyclitis, uveitis chronica
94.0
8.5
9
*
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
+∞
8.4
8
*
3641A
ICD-9 Finland
Disorders of iris and ciliary body, Chronic iridocyclitis
+∞
8.4
8
*
S01BA01
ATC
dexamethasone; ophthalmic
7.4
8.3
19
28
WX100
NOMESCO Finland
Conjunctival surface anesthesia
3.0
8.1
41
159
S01EE05
ATC
tafluprost; ophthalmic
6.7
7.8
19
31
Z01.8
ICD-10 Finland
Other specified special examinations
2.7
7.7
51
228
S01EA03
ATC
apraclonidine; ophthalmic
19.3
7.7
11
6
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
83.1
7.5
8
*
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
6.7
7.4
18
29
36608
ICD-8 Finland
Other inflammation of uveal tract, Alia definita
+∞
7.3
7
*
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
+∞
7.3
7
*
Z3229
NOMESCO Finland
Other healthcare associate professional
3.3
7.2
30
103
ZX198
NOMESCO Finland
Other local administration
31.3
7.2
9
*
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
10.6
7.1
13
13
H40.0
ICD-10 Finland
Glaucoma suspect
3.6
7.1
25
77
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
9.9
6.9
13
14
CM2S4
NOMESCO Finland
Follow-up photography of age-related macular degeneration lesions
41.5
6.8
8
*
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
41.5
6.8
8
*
H30.2
ICD-10 Finland
Posterior cyclitis
41.5
6.8
8
*
ZXA05
NOMESCO Finland
Left side
2.4
6.7
62
322
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
9.2
6.7
13
15
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
72.1
6.5
7
*
CKC15
NOMESCO Finland
Panretinal photocoagulation
18.8
6.3
9
5
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
+∞
6.3
6
*
TCH10
NOMESCO Finland
Needle aspiration of aqueous from anterior chamber
+∞
6.3
6
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
27.7
6.3
8
*
A10AA02, ,
ATC
5.5
6.2
17
33
H34.8
ICD-10 Finland
Other retinal vascular occlusions
7.1
6.2
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
26
40
7.35
16.65
1.6
1.4
—
—
—
0
0
14
15
9.96
7.42
1.2
1.3
—
—
—
0
0
12
10
12.69
7.18
1.2
1.2
—
—
—
0
0
18
35
5.56
6.51
1.8
1.6
—
—
—
0
0
37
180
2.30
4.53
10.0
5.3
1.03
1.04
mmol/l
0.06
37
164
7
6
12.03
4.31
3.0
1.8
535.29
1203.83
u/ml
—
7
6
7
9
8.02
3.59
1.0
1.2
—
—
—
0
0
5
6
8.51
2.76
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
6
8.51
2.76
1.0
1.3
—
—
—
0
0
7
14
5.14
2.75
1.6
1.1
—
—
—
0
0
90
679
1.61
2.67
3.1
2.8
—
—
—
0
0
8
20
4.12
2.59
1.3
1.0
—
—
—
0
0
88
676
1.55
2.34
6.5
4.2
34.41
35.33
g/l
0.85
81
626
22
116
2.01
2.21
2.9
2.6
228.32
209.29
ng/l
0.06
22
99
9
30
3.09
2.17
1.1
1.8
4.29
3.91
mmol/l
—
9
30
10
37
2.79
2.10
1.2
1.7
434.40
441.95
mg/l
—
10
37
8
27
3.05
1.96
3.3
1.7
—
—
—
0
0
82
639
1.49
1.96
2.1
1.9
91.85
95.47
pmol/l
0.26
49
301
6
16
3.83
1.95
3.2
1.4
—
—
—
0
0
43
291
1.61
1.92
4.2
3.3
45.28
121.10
ng/l
1.12
32
237
96
777
1.47
1.87
9.4
6.1
1.22
1.22
mmol/l
0.05
85
657
11
47
2.42
1.81
7.3
3.9
—
3.37
—
0
7
62
463
1.50
1.79
5.1
3.7
19.10
8.33
mg/mmol
0.76
46
293
17
89
2.00
1.76
1.2
1.7
—
—
—
0
0
21
122
1.81
1.62
1.5
1.6
—
—
—
0
0
36
244
1.58
1.60
2.2
1.9
—
—
—
0
0
27
170
1.68
1.59
2.0
1.7
—
—
—
0
0
6
21
2.91
1.51
2.3
1.8
—
—
—
0
0
9
38
2.43
1.47
3.0
1.7
—
—
—
0
0
6
22
2.78
1.44
1.0
1.8
—
—
—
0
0
9
40
2.31
1.42
3.1
1.7
—
—
—
0
0
11
53
2.14
1.41
1.5
1.8
—
—
—
0
0
7
29
2.47
1.40
2.1
1.7
—
—
—
0
0
92
770
1.37
1.36
6.5
4.0
0.00
0.00
estimate
-0.00
20
153
34
237
1.53
1.35
3.9
2.2
14.34
12.53
umol/l
0.75
34
214
92
772
1.36
1.33
20.6
16.2
1.41
1.35
inr
0.21
27
236
8
34
2.41
1.31
1.1
1.7
3.75
21.81
e6/l
—
8
27
8
34
2.41
1.31
1.3
1.8
888.25
173.50
e6/l
—
8
28
10
48
2.14
1.30
1.3
1.1
—
—
—
0
0
13
70
1.92
1.27
1.2
1.3
—
—
—
0
0
16
93
1.79
1.25
6.0
3.0
0.94
1.21
%
0.97
16
93
6
25
2.44
1.25
1.0
1.8
—
—
—
0
0
80
662
1.35
1.25
4.6
4.2
43.41
44.21
ng/l
0.02
58
493
10
49
2.10
1.24
1.3
1.1
—
—
—
0
0
20
125
1.67
1.23
5.6
3.5
68.46
66.10
g/l
0.74
20
110
8
37
2.21
1.23
4.1
2.7
102.75
105.86
mmol/l
—
8
37
11
57
1.99
1.19
2.2
2.1
—
—
—
0
0
28
196
1.50
1.10
9.0
8.9
—
—
—
0
0
5
21
2.42
1.09
3.6
1.5
—
—
—
0
0
7
33
2.16
1.06
1.7
1.4
—
—
—
0
0
125
1121
1.32
1.06
4.7
3.9
15.04
14.99
pmol/l
0.09
112
986
90
775
1.30
1.02
6.6
4.1
0.00
0.00
estimate
-0.00
18
135
25
174
1.50
1.01
2.0
1.8
—
—
—
0
0
19
125
1.58
0.98
2.7
3.0
75.67
61.80
ml/min/173m2
—
6
51
0
31
0.00
0.97
0.0
1.4
—
—
—
0
0
125
1131
1.30
0.94
5.1
4.0
14.82
13.43
mm/h
0.42
118
1025
6
27
2.26
0.94
1.8
1.2
—
—
—
0
0
99
871
1.28
0.93
12.8
9.0
3.97
4.24
e9/l
0.80
91
764
19
127
1.55
0.92
2.1
2.0
0.21
0.21
g/l
0.06
19
115
159
1491
1.37
0.90
21.5
15.1
25.55
24.89
mg/l
0.08
131
1178
14
88
1.64
0.87
3.7
2.6
2.20
1.60
mmol/l
—
8
64
6
32
1.90
0.82
2.5
2.5
386.73
69.15
ug/min
—
6
22
9
53
1.73
0.76
4.9
2.6
24.39
24.98
mmol/l
—
9
48
87
767
1.24
0.76
8.4
5.5
0.00
0.00
estimate
-0.00
20
141
9
55
1.67
0.74
6.2
3.6
—
—
—
0
0
42
343
1.29
0.69
1.8
1.8
1.35
1.42
mg/l
0.07
34
271
41
338
1.27
0.63
3.2
2.4
—
—
—
0
0
5
30
1.68
0.62
4.8
1.7
—
—
—
0
0
5
30
1.68
0.62
4.8
1.7
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
112.30
—
0
20
0
22
0.00
0.59
0.0
1.1
—
1.29
—
0
7
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
1.80
—
0
10
14
98
1.46
0.58
3.9
2.4
4.99
4.97
kpa
0.03
14
91
6
35
1.74
0.58
2.0
1.3
—
—
—
0
0
170
1637
1.31
0.56
31.4
22.4
38.99
39.74
%
0.80
153
1529
6
39
1.56
0.53
1.3
1.3
67.38
357.65
pmol/l
—
6
39
143
1357
1.20
0.51
5.8
4.8
2.05
2.00
mu/l
0.19
134
1201
7
46
1.54
0.49
1.1
1.5
—
—
—
0
0
7
47
1.51
0.48
1.3
2.3
—
—
—
0
0
146
1391
1.20
0.48
7.6
6.0
42.22
40.47
mmol/mol
1.06
138
1282
41
350
1.22
0.48
1.8
1.9
419.62
453.80
pmol/l
0.27
34
288
20
156
1.31
0.47
1.6
2.5
6.34
5.52
ug/l
0.15
20
135
5
82
0.60
0.47
1.0
1.0
—
—
—
0
0
14
104
1.37
0.44
1.4
1.3
—
—
—
0
0
11
78
1.43
0.44
2.7
2.7
4.51
4.57
pmol/l
0.04
11
68
6
93
0.63
0.43
1.8
1.5
—
—
—
0
0
13
96
1.38
0.43
12.8
3.5
24.45
24.96
mmol/l
0.20
13
96
0
15
0.00
0.41
0.0
1.1
—
96.20
—
0
15
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
17
0.00
0.41
0.0
2.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.8
—
3.67
—
0
6
5
34
1.48
0.40
1.2
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
4.5
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
5
36
1.40
0.38
1.2
1.2
—
—
—
0
0
48
427
1.16
0.36
6.0
4.1
0.00
0.00
estimate
-0.00
18
139
29
247
1.20
0.35
4.0
2.9
2.06
2.45
e6/l
0.18
21
138
6
43
1.41
0.35
2.2
1.7
—
—
—
0
0
77
828
0.88
0.33
2.3
2.8
—
—
—
0
0
30
259
1.19
0.32
3.9
2.7
0.66
1.07
e6/l
0.81
23
149
22
185
1.21
0.31
4.2
5.7
-0.40
1.36
mmol/l
0.74
14
144
20
168
1.21
0.28
3.2
3.6
—
—
—
0
0
18
150
1.22
0.27
1.4
1.9
411.72
361.68
nmol/l
0.92
18
133
66
617
1.11
0.23
5.9
4.1
—
—
—
0
0
5
37
1.36
0.23
1.8
1.5
—
—
—
0
0
5
38
1.32
0.23
1.4
2.3
—
—
—
0
0
5
39
1.29
0.23
2.8
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
2.3
—
13.47
—
0
10
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
6
49
1.23
0.20
1.8
1.9
—
—
—
0
0
61
574
1.09
0.19
5.4
3.1
—
—
—
0
0
44
408
1.10
0.18
3.9
2.8
369.84
10717.08
umol/l
2.99
38
331
26
234
1.13
0.18
1.4
1.3
69.67
46.39
iu/ml
—
9
75
7
62
1.13
0.17
5.4
1.6
9.96
9.25
g/l
—
7
53
57
537
1.09
0.17
4.1
3.1
2.32
2.35
mmol/l
0.97
50
473
29
317
0.90
0.16
1.3
1.2
0.70
1.90
u/ml
—
6
81
147
1440
1.09
0.15
4.9
4.5
4.28
4.55
mmol/l
3.14
139
1312
18
200
0.89
0.13
1.1
1.5
—
—
—
0
0
150
1477
1.07
0.11
5.7
5.1
2.39
2.66
mmol/l
3.93
141
1336
10
86
1.17
0.11
1.9
2.1
—
—
—
0
0
145
1427
1.06
0.10
4.8
4.5
1.44
1.47
mmol/l
0.36
135
1287
5
45
1.11
0.10
2.6
1.8
0.00
0.00
g/l
—
5
40
5
47
1.07
0.09
1.8
1.4
—
—
—
0
0
48
460
1.06
0.09
4.2
5.1
2.38
2.88
ug/l
0.21
42
407
7
67
1.05
0.08
6.4
1.6
—
—
—
0
0
7
67
1.05
0.08
6.4
1.6
6.66
7.53
g/l
—
7
59
7
67
1.05
0.08
6.4
1.6
7.51
3.42
g/l
—
7
59
21
196
1.08
0.07
1.5
1.4
—
—
—
0
0
143
1447
0.96
0.07
5.3
4.7
6.18
6.00
mmol/l
0.99
134
1300
16
172
0.92
0.06
2.6
3.8
2.48
49.04
ug/l
—
10
137
140
1387
1.03
0.04
4.4
4.0
1.23
1.25
mmol/l
0.12
129
1244
11
102
1.08
0.03
2.0
2.1
—
—
—
0
0
21
219
0.95
0.03
1.2
1.3
1.10
13.83
u/ml
—
5
86
18
186
0.96
0.00
2.5
2.3
6.78
8.47
umol/l
0.28
18
158
37
369
1.00
0.00
3.8
4.6
19.31
21.32
%
0.58
17
179
28
275
1.02
0.00
3.0
3.1
0.55
0.77
ug/l
1.11
21
178
140
1405
0.99
0.00
19.4
14.4
75.59
76.84
ml/min/173m2
0.25
119
1140
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
0.33
—
0
5
0
7
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.92
-0.00
2.6
1.7
5.72
0.53
g/l
—
5
47
5
49
1.02
-0.00
2.6
1.8
0.00
0.00
g/l
—
5
44
0
9
0.00
-0.00
0.0
3.6
—
—
—
0
0
5
51
0.98
-0.00
2.6
1.7
40.58
38.62
g/l
—
5
43
8
87
0.92
-0.00
6.9
5.3
22.28
24.81
mmol/l
—
8
87
0
5
0.00
-0.00
0.0
1.2
—
119.00
—
0
5
0
5
0.00
-0.00
0.0
3.6
—
73.00
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
9.91
—
0
6
0
9
0.00
-0.00
0.0
3.6
—
—
—
0
0
6
59
1.02
-0.00
7.3
1.7
2.52
2.89
g/l
—
6
51
0
8
0.00
-0.00
0.0
1.1
—
10.61
—
0
8
Mortality – FinRegistry
↥Association
Association between endpoint H7_OTHENDOPHTHALMITIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_OTHENDOPHTHALMITIS | 1.387 [1.15, 1.67] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.049 |
During the follow-up period (1.1.1998 — 31.12.2019), 280 out of 691 females with H7_OTHENDOPHTHALMITIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_OTHENDOPHTHALMITIS | 1.786 [1.39, 2.3] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 230 out of 557 males with H7_OTHENDOPHTHALMITIS died.
Mortality risk
Mortality risk for people of age
years, who have H7_OTHENDOPHTHALMITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.091% | 0.253% |
| 5 | 0.739% | 1.803% |
| 10 | 1.913% | 4.433% |
| 15 | 3.556% | 8.403% |
| 20 | 6.099% | 13.372% |
Relationships between endpoints
↥Index endpoint: H7_OTHENDOPHTHALMITIS – Other endophthalmitis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data